WHISTLER MEDICAL MARIJUANA
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $915k | Seed | |
N/A | $1.5m | Early VC | |
N/A | $404k | Early VC | |
N/A | $1.0m | Early VC | |
N/A | $400k | Early VC | |
$2.2m | Seed | ||
* | N/A | Acquisition | |
Total Funding | €5.8m |
Related Content
Recent News about WHISTLER MEDICAL MARIJUANA
EditWhistler Medical Marijuana Corporation (WMMC) operates in the medical cannabis industry, specializing in the production and distribution of organic certified cannabis products. The company serves patients seeking medical cannabis solutions, focusing on high-quality, chemical-free cannabis oils and topicals. WMMC's market includes individuals with medical prescriptions for cannabis, primarily within Canada. The business model revolves around cultivating organic cannabis, extracting oils using CO2 methods, and blending these with premium organic coconut and extra virgin olive oils. Revenue is generated through direct sales of these products via their online platform, ensuring compliance with legal age verification and safety measures.
WMMC differentiates itself by using pollutant-free glacial waters and avoiding hydroponics, aeroponics, and pesticides, emphasizing natural and sustainable farming practices. The company also offers a range of dried cannabis strains, all FVOPA organic certified, catering to diverse medical needs. During the COVID-19 pandemic, WMMC has maintained operations, ensuring continuous delivery through Canada Post and Purolator with enhanced safety measures.
Keywords: organic cannabis, medical marijuana, cannabis oils, topicals, chemical-free, FVOPA certified, CO2 extraction, sustainable farming, Canadian market, patient-focused.